Hjem › Multipelt myelom › Iowa › Cedar Rapids
Kliniske studier for Multipelt myelom i Cedar Rapids, IA
15 studier for Multipelt myelom søker deltakere på steder i og rundt Cedar Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi unna
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
RekruttererFase 1
- Research Site, Iowa City · 25 mi unna
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 3
- University of Iowa Hospital and Clinics, Iowa City · 25 mi unna
Collection of Tissue Samples for Cancer Research
RekruttererObservasjonsstudie
- University of Iowa, Iowa City · 25 mi unna
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekruttererFase 2
- University of Iowa, Iowa City · 25 mi unna
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
RekruttererFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
RekruttererFase 1/2
- Research Site, Iowa City · 25 mi unna
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RekruttererFase 3
- Research Site, Iowa City · 25 mi unna
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
RekruttererFase 2
- University of Iowa, Iowa City · 25 mi unna
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
RekruttererFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · 25 mi unna
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
RekruttererFase 2
- University of Iowa, Iowa City · 25 mi unna
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
RekruttererFase 1
- University of Iowa Health Care, Iowa City · 25 mi unna
Sleep Apnea in Patients With MGUS and MM
RekruttererObservasjonsstudie
- University of Iowa, Iowa City · 25 mi unna
Activity Levels in Bone Marrow Transplant Patients
RekruttererObservasjonsstudie
- University of Iowa, Iowa City · 25 mi unna
Limited-duration Teclistamab
RekruttererFase 2
- University of Iowa Hospitals and Clinics, Iowa City · 25 mi unna
Multipelt myelom-studier i andre byer
- New York City, NY60 studier
- Boston, MA42 studier
- Atlanta, GA41 studier
- Houston, TX38 studier
- Durham, NC37 studier
- Nashville, TN32 studier
- Denver, CO27 studier
- Rochester, MN24 studier
- St. Louis, MO24 studier
- Columbus, OH24 studier
- Baldwin Park, CA23 studier
- Chicago, IL22 studier
Andre studier i Cedar Rapids
- Ikke-småcellet lungekreft20 studier
- Brystkreft17 studier
- Akut myelogen leukemi16 studier
- Kreft (alle typer)15 studier
- Lungekreft14 studier
- Kolorektal kreft13 studier
- Prostatakreft12 studier
- Plateepitelcancer i hode og hals12 studier
- Melanom10 studier
- Slag10 studier
- Metastatisk kreft9 studier
- Endometriekreft9 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.